copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Novartis Novartis is an innovative medicines company Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease Our medicines reach 296 million people worldwide
Novartis - Wikipedia Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024 [4][5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate
Novartis Pharmaceuticals Corporation - Drugs. com Novartis Pharmaceuticals Corporation manufactures, markets and or distributes more than 67 drugs in the United States Medications listed here may also be marketed under different names in different countries
Novartis AG | Swiss Pharmaceutical Giant | Britannica Money Novartis AG, Swiss company that is one of the world’s largest manufacturers of pharmaceuticals It was formed in 1997 from the merger of two major Swiss drug companies, Ciba-Geigy AG and Sandoz AG
Welcome to the Novartis US Medical Affairs Website! This resource is intended to support the sharing of scientific information regarding Novartis products and technology platforms, their development, investigation, or clinical research, along with related therapeutic areas of interest with healthcare professionals
Novartis makes $23 billion investment in Americas health - Axios Novartis is working to ensure both happen in the United States, strengthening outcomes for patients, creating jobs and driving progress in communities nationwide Here's the deal: Novartis plans to invest $23 billion over the next five years, creating more than 1,000 jobs and supporting 4,000 more across the U S supply chain
Novartis breaks ground on Triangle expansion :: WRAL. com Novartis Gene Therapies will break ground Thursday on a new Triangle expansion The Swiss medicine developer and manufacturer is planning to spend $770 million on new buildings and renovations o